ArticleJournal of proteome research2026
Deciphering Allergen Peptides for Dermatological and Cosmetic Applications with Explainable Artificial Intelligence.
Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
This study explores the potential of explainable artificial intelligence to advance our understanding of allergen peptides in the context of dermatology and cosmetics. We present a hybrid deep learning framework that integrates Temporal Convolutional Networks (TCN) and stacked Long Short-Term Memory (LSTM) architectures, enhanced with Evolutionary Scale Modeling (ESM) embeddings, to decode allergenic motifs embedded in peptide sequences. The ESM embeddings allow the model to capture both the evolutionary context and structural nuances of amino acids, enabling accurate classification of allergenic potential. Beyond classification, the framework emphasizes interpretability using state-of-the-art explainability tools such as Anchor, LIME, and SHAP. Anchor identifies minimal and decisive motifs responsible for allergenic activity, while LIME and SHAP provide a distributed importance map of k-mers, highlighting synergistic contributions across the peptide sequence. These methods ensure that the model output is not only precise, but it may also be biologically meaningful, opening a path to rational peptide modification strategies. In dermatology and cosmetic science, this approach represents a transformative tool, providing a scalable and transparent means to screen peptide-based formulations for allergenic risks, facilitates the design of safer bioactive peptides for therapeutic or cosmetic use, and supports regulatory compliance by grounding computational predictions in mechanistic explanations. Ultimately, the study bridges cutting-edge machine learning with dermatology and cosmetics, fostering the development of innovative, safe, and patient-centered cosmetic products.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.